Skip to main content
Equibles

MORGAN STANLEY

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,927,614
-$1,024,600 QoQ
Shares Held
1,471,462
-21.2% QoQ
Ownership
0.582%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 130 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 28% Shared 0% None 72%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. LCTX ranks #216 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in LCTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,927,614 1,471,462
2026-03-31 $2,952,214 1,868,491
2025-12-31 $3,337,766 1,998,663
2025-09-30 $1,700,900 1,006,451
2025-06-30 $762,089 837,463
2025-03-31 $435,949 968,781
2024-12-31 $330,029 660,061
2024-09-30 $771,943 848,291
2024-06-30 $526,629 526,629
2024-03-31 $678,868 458,697
2023-12-31 $520,543 477,566
2023-09-30 $327,819 277,816
2023-06-30 $214,640 152,229
2023-03-31 $459,180 306,120
2022-12-31 $154,196 131,793
2022-09-30 $70,693 62,562
2022-06-30 $203,668 128,905
2022-03-31 $375,997 244,155
2021-12-31 $1,294,961 528,557
2021-09-30 $315,862 125,343
2021-06-30 $366,970 128,762
2021-03-31 $259,737 110,527
2020-12-31 $228,218 129,670
2020-09-30 $50,179 53,383
2020-06-30 $73,554 84,546
2020-03-31 $48,428 58,348